# A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer

> **NCT02705469** · PHASE1 · COMPLETED · sponsor: **Zenith Epigenetics** · enrollment: 44 (estimated)

## Conditions studied

- Metastatic Castration-Resistant Prostate Cancer

## Interventions

- **DRUG:** ZEN003694

## Key facts

- **NCT ID:** NCT02705469
- **Lead sponsor:** Zenith Epigenetics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2017-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02705469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02705469, "A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02705469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*